← Back to headlines
ADMA Biologics Gains After Refuting Short Seller Claims
ADMA Biologics saw its stock gain after successfully refuting claims made by a short seller, restoring investor confidence.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Tesla Prepares for Cybercab Launch in August with Employee Rides
24m ago
Trump Crypto Firm Supports AI Venture with Restricted Chinese Companies
1h ago
Otedola Increases First HoldCo Stake with N20.7 Billion Share Purchase
2h ago
Alphabet Launches Inaugural Australian Dollar Bond Sale for AI Investment
3h ago